Pieter Droppert

Pieter Droppert is a management consultant, lawyer, science writer and editor of the Biotech Strategy Blog (http://biotechstrategyblog.com) on science, innovation and new product development in the pharma & biotech industries.

Recent posts

A Revolution is Taking Place in the Treatment of Blood Cancers
I try to avoid sensationalizing early clinical trial results presented at medical conferences, what’s commonly known as “hype over hope.” But at this year’s annual meeting of the American Society of... Read more »
Is Crowdfunding The Future For Biomedical Research?
Microryza.com (not the catchiest of names) is a crowdfunding platform for research that raises money over the Internet from individuals who are willing to donate small amounts to fund a specific... Read more »
Prostate Cancer Drug Winners and Losers at ASCO GU
The latest clinical research in prostate cancer is being presented at the American Society of Clinical Oncology Genitorinary Cancers Symposium (ASCO GU) in Orlando, FL. Presentations started yesterday, and run through... Read more »
Emerging Challenges of Prostate Cancer Drug Development
The world’s largest cancer meeting of scientists, physicians and industry has just ended in Chicago. The annual meeting of the American Society of Clinical Oncology (ASCO) attracted over 30,000 attendees to... Read more »
J&J Prostate Cancer Trial Shouldn’t Have Been Stopped Early
One of the more anticipated clinical trials at this year’s American Society of Clinical Oncology (ASCO) meeting was for Johnson & Johnson’s abiraterone (Zytiga) in prostate cancer patients. This study, known... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

From Our Editors · Special Report
Containing Coronavirus Through Innovation and Investment
Top biotech and investment players offer their best plans and current progress in stemming and ultimately defeating the worldwide pandemic

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Millendo May Restructure After Prader-Willi Drug Fails Pivotal Test

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Menlo’s Itching Drug Racks Up Two More Trial Failures, Program Ends

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Organovo Future Unclear After Shareholders Reject Tarveda Merger

GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Xilio Unveils New Name, $100M to Bring Targeted Cancer Drugs to Clinic

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Xcelerating Life Sciences Boston (interactive online event)

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

Pieter Droppert

Recent posts

A Revolution is Taking Place in the Treatment of Blood Cancers

Is Crowdfunding The Future For Biomedical Research?

Prostate Cancer Drug Winners and Losers at ASCO GU

Emerging Challenges of Prostate Cancer Drug Development

J&J Prostate Cancer Trial Shouldn’t Have Been Stopped Early

Underwriters and Partners

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

Containing Coronavirus Through Innovation and Investment

What’s Next in Neuroscience Therapies

Xconomy on Demand

We offer a number of ways to subscribe for free!